| 000 | 02856nam a22004215i 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_BiomedLife_2019 | ||
| 999 |
_c116762 _d116762 _x1 |
||
| 001 | 116762 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230110040245.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 190924s2019 gw | s |||| 0|eng d | ||
| 020 | _a9783030310004 | ||
| 024 | 7 |
_a10.1007/978-3-030-31000-4 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC899 _b2019 EB |
|
| 100 | 1 |
_aKoo, Kevin M. _eautor _9671964 |
|
| 245 | 1 | 0 |
_aAdvancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics _cby Kevin M. Koo. |
| 250 | _a1st ed. 2019. | ||
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2019 |
|
| 300 | _a1 recurso en línea (XIII, 102 páginas) | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 |
_aSpringer Theses Recognizing Outstanding Ph.D. Research _x2190-5053 |
|
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aUnifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label -Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling. | |
| 520 | 3 | _aThis book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development. | |
| 650 | 7 |
_2embne _aPróstata _xCáncer _9182337 |
|
| 650 | 7 |
_2embne _aMarcadores biológicos _9162047 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030309992 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030310011 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030310028 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-31000-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_aSI _cm _dz _feng _ggw _h0 _b01/2020 _ek _zSI |
||